BackCue Biopharma Overview

Cue Biopharma Total Liabilities

Latest total liabilities for CUE: $9.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.27M
40.86% YoYΔ $-6.41M vs prior year quarter

Peer average / median

Loading

Cue Biopharma Total Liabilities History

Loading

Cue Biopharma vs. peers: Total Liabilities Comparison

Loading

Cue Biopharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cue Biopharma (CUE) FAQ

As of the most recent data (March 2026), CUE shows a total liabilities of $9.3M. That compares with $16M in the prior-year period — down 40.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CUE's total liabilities is now $9.3M (was $16M) — a 40.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cue Biopharma is outperforming or lagging.

Tracking CUE's total liabilities over time shows whether Cue Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $16M in the prior-year period — down 40.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Cue Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $9.3M) with ownership activity and broader fundamentals.

Cue Biopharma's total liabilities is $9.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.